Clarius Group LLC’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.36M Hold
1,209,646
0.13% 65
2025
Q3
$1.02M Buy
1,209,646
+149,186
+14% +$110K 0.06% 125
2025
Q2
$769K Buy
1,060,460
+193,874
+22% +$146K 0.04% 178
2025
Q1
$746K Buy
866,586
+230,054
+36% +$342K 0.05% 184
2024
Q4
$1.07M Hold
636,532
0.07% 115
2024
Q3
$1.81M Hold
636,532
0.13% 76
2024
Q2
$1.49M Buy
636,532
+16,661
+3% +$43.5K 0.11% 90
2024
Q1
$1.82M Buy
619,871
+22,102
+4% +$62.7K 0.13% 76
2023
Q4
$1.79M Hold
597,769
0.15% 79
2023
Q3
$1.89M Sell
597,769
-203
-0% -$661 0.18% 66
2023
Q2
$2.31M Hold
597,972
0.18% 67
2023
Q1
$1.66M Buy
597,972
+10,667
+2% +$22.4K 0.14% 82
2022
Q4
$1.06M Buy
587,305
+82,901
+16% +$160K 0.1% 129
2022
Q3
$1.07M Hold
504,404
0.11% 115
2022
Q2
$1.36M Buy
504,404
+77,480
+18% +$288K 0.14% 99
2022
Q1
$2.21M Hold
426,924
0.17% 69
2021
Q4
$2.21M Buy
426,924
+408,663
+2,238% +$2.19M 0.17% 69
2021
Q3
$112K Buy
+18,261
New +$146K 0.01% 424

Other funds holding NAUT

Clarius Group LLC's NAUT Position: Q4 2025 in Review

Clarius Group LLC held its Nautilus Biotechnolgy (NAUT) position steady in Q4 2025 at 1,209,646 shares worth $2.36M. The position accounts for 0.13% of the portfolio, ranked #65.

Clarius Group LLC first reported a position in NAUT in Q3 2021 and has held it in 18 quarters since. 68 funds tracked by Wall St. Rank hold NAUT as of Q4 2025.

  • Clarius Group LLC held 1,209,646 shares of Nautilus Biotechnolgy worth $2.36M as of Q4 2025.
  • Clarius Group LLC left its Nautilus Biotechnolgy share count unchanged in Q4 2025.
  • Nautilus Biotechnolgy made up 0.13% of Clarius Group LLC's portfolio in Q4 2025, its #65 holding.
  • Clarius Group LLC first reported a position in Nautilus Biotechnolgy in Q3 2021 and has held it in 18 quarters since.
  • 68 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2025.

Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.